Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -4.160% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a) Cc1cc(C)n2nc(SCC(=O)Nc3ccccc3)nc2n1
b) O=C(Nc1ccc(F)cc1)Nc1ccc([N+](=O)[O-])cn1
c) O=C(NC(=S)Nc1ccccc1N1CCOCC1)c1ccc(-c2cccc(Cl)c2)o1
Answer: a. Cc1cc(C)n2nc(SCC(=O)Nc3ccccc3)nc2n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(C)n2nc(SCC(=O)Nc3ccccc3)nc2n1
Cc1cc(C)n2nc(SCC(=O)Nc3ccccc3)nc2n1
2-[(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)sulfanyl]-N-phenylacetamide